Phthalazinone Pyrazoles as Potent, Selective, and Orally Bioavailable Inhibitors of Aurora-A Kinase

被引：75

作者：

Prime, Michael E. ^{[1
]}

Courtney, Stephen M. ^{[1
]}

Brookfield, Frederick A. ^{[1
]}

Marston, Richard W. ^{[1
]}

Walker, Victoria ^{[1
]}

Warne, Justin ^{[1
]}

Boyd, Andrew E.

Kairies, Norman A. ^{[3
]}

von der Saal, Wolfgang ^{[2
]}

Limberg, Anja ^{[2
]}

Georges, Guy ^{[2
]}

Engh, Richard A. ^{[3
]}

Goller, Bernhard ^{[2
]}

Rueger, Petra ^{[2
]}

Rueth, Matthias ^{[2
]}

机构：

[1] Evotec UK Ltd, Abingdon OX14 4SA, Oxon, England

[2] Roche Diagnost GmbH, Pharma Res Penzberg, D-82372 Penzberg, Germany

[3] Max Planck Inst Biochem, D-82152 Planegg Martinsried, Germany

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2011年 / 54卷 / 01期

关键词：

AURORA/IP11-RELATED PROTEIN-KINASE; SMALL-MOLECULE INHIBITOR; IN-VIVO; ANTICANCER AGENTS; B KINASE; SPINDLE; CELLS; CYTOKINESIS; CHECKPOINT; DISCOVERY;

D O I：

10.1021/jm101346r

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The inhibition of Aurora kinases in order to arrest mitosis and subsequently inhibit tumor growth via apoptosis of proliferating cells has generated significant discussion within the literature We report a novel class of Aurora kinase inhibitors based upon a phthalazinone pyrazole scoff old The development of the phthalazinone template resulted in a potent Aurora-A selective series of compounds (typically > 1000-fold selectivity over Aurora-B) that display good pharmacological profiles with significantly improved oral bioavailability compared to the well studied Aurora inhibitor VX-680

引用

页码：312 / 319

页数：8

共 50 条

[41] Orally bioavailable potent soluble epoxide hydrolase inhibitors
Hwang, Sung Hee
Tsai, Hsing-Ju
Liu, Jun-Yan
Morisseau, Christophe
Hammock, Bruce D.
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (16) : 3825 - 3840
[42] Single step synthesis of new fused pyrimidine derivatives and their evaluation as potent Aurora-A kinase inhibitors
Shaaban, Mohamed R.
Saleh, Tamer S.
Mayhoub, Abdelrahman S.
Farag, Ahmad M.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (09) : 3690 - 3695
[43] Discovery of Potent, Orally Bioavailable Phthalazinone Bradykinin B1 Receptor Antagonists
Biswas, Kaustav
Peterkin, Tanya A. N.
Bryan, Marian C.
Arik, Leyla
Lehto, Sonya G.
Sun, Hong
Hsieh, Feng-Yin
Xu, Cen
Fremeau, Robert T.
Allen, Jennifer R.
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (20) : 7232 - 7246
[44] Discovery of orally bioavailable imidazo[1,2-a]pyrazine-based Aurora kinase inhibitors
Belanger, David B.
Williams, Michael J.
Curran, Patrick J.
Mandal, Amit K.
Meng, Zhaoyang
Rainka, Matthew P.
Yu, Tao
Shih, Neng-Yang
Siddiqui, M. Arshad
Liu, Ming
Tevar, Seema
Lee, Suining
Liang, Lianzhu
Gray, Kimberly
Yaremko, Bohdan
Jones, Jennifer
Smith, Elizabeth B.
Prelusky, Dan B.
Basso, Andrea D.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (22) : 6739 - 6743
[45] Discovery of novel and potent thiazoloquinazolines as selective Aurora A and B kinase inhibitors
Jung, FH
Pasquet, G
Lambert-van der Brempt, C
Lohmann, JJM
Warin, N
Renaud, F
Germain, H
De Savi, C
Roberts, N
Johnson, T
Dousson, C
Hill, GB
Mortlock, AA
Heron, N
Wilkinson, RW
Wedge, SR
Heaton, SP
Odedra, R
Keen, NJ
Green, S
Brown, E
Thompson, K
Brightwell, S
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (03) : 955 - 970
[46] Potent, Selective and Orally Bioavailable Dihydropyrimidine Inhibitors of Rho Kinase (ROCK1) as Potential Therapeutic Agents for Cardiovascular Diseases
Sehon, Clark A.
Wang, Gren Z.
Viet, Andrew Q.
Goodman, Krista B.
Dowdell, Sarah E.
Elkins, Patricia A.
Semus, Simon F.
Evans, Christopher
Jolivette, Larry J.
Kirkpatrick, Robert B.
Dul, Edward
Khandekar, Sanjay S.
Yi, Tracey
Wright, Lois L.
Srnith, Gary K.
Behm, David J.
Bentley, Ross
Doe, Christopher P.
Hu, Erding
Lee, Dennis
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (21) : 6631 - 6634
[47] Evaluation of the anti-hepatitis C virus effect of novel potent, selective, and orally bioavailable JNK and VEGFR kinase inhibitors
Raboisson, Pierre
Lenz, Oliver
Lin, Tse-I
Surleraux, Dominique
Chakravarty, Sarvajit
Scholliers, Annick
Vermeiren, Katrien
Delouvroy, Frederic
Verbinnen, Thierry
Simmen, Kenneth
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (07) : 1843 - 1849
[48] Syntheses of potent, selective, and orally bioavailable indazole-pyridine series of protein kinase B/Akt inhibitors with reduced hypotension
Zhu, Gui-Dong
Gandhi, Viraj B.
Gong, Jianchun
Thomas, Sheela
Woods, Keith W.
Song, Xiaohong
Li, Tongmei
Diebold, R. Bruce
Luo, Yan
Liu, Xuesong
Guan, Ran
Klinghofer, Vered
Johnson, Eric F.
Bouska, Jennifer
Olson, Amanda
Marsh, Kennan C.
Stoll, Vincent S.
Mamo, Mulugeta
Polakowski, James
Campbell, Thomas J.
Martin, Ruth L.
Gintant, Gary A.
Penning, Thomas D.
Li, Qun
Rosenberg, Saul H.
Giranda, Vincent L.
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (13) : 2990 - 3003
[49] Discovery of Novel 3-Quinoline Carboxamides as Potent, Selective, and Orally Bioavailable Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase
Degorce, Sebastien L.
Barlaam, Bernard
Cadogan, Elaine
Dishington, Allan
Ducray, Richard
Glossop, Steven C.
Hassall, Lorraine A.
Lach, Franck
Lau, Alan
McGuire, Thomas M.
Nowak, Thorsten
Ouvry, Gilles
Pike, Kurt G.
Thomason, Andrew G.
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (13) : 6281 - 6292
[50] Design and synthesis of potent, orally bioavailable dihydroquinazolinone inhibitors of p38 MAP kinase
Stelmach, JE
Liu, LP
Patela, SB
Pivnichny, JV
Scapin, G
Singh, S
Hop, CECA
Wang, Z
Strauss, JR
Cameron, PM
Nichols, EA
O'Keefe, SJ
O'Neill, EA
Schmatz, DM
Schwartz, CD
Thompson, CM
Zaller, DM
Doherty, JB
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (02) : 277 - 280

← 1 2 3 4 5 →